Lawmakers, Administration To Craft Proposal Giving FDA Authority Over Generic Biotechnology Drugs (Medical News Today)
At a Senate Finance Committee hearing on Wednesday, Sen. Charles Schumer (D-N.Y.) told HHS Secretary Mike Leavitt that he had spoken with FDA Commissioner Andrew von Eschenbach about crafting a proposal that would give FDA the authority to regulate generic versions of biotechnology drugs and that the two agreed to "sit down and try to do something jointly," CongressDaily reports.

Medtronic Receives U.S. FDA Approval For New Neurostimulator With Innovative Patient Programmer (Medical News Today)
Medtronic, Inc. (NYSE:MDT), announced it has received U.S. Food and Drug Administration (FDA) approval to market the RestoreULTRA neurostimulation system for the treatment of chronic intractable pain of the trunk and/or limbs (chronic back and leg pain).

FDA OKs First Generic Fosamax (MedicineNet.com)
Title: FDA OKs First Generic Fosamax Category: Health News Created: 2/7/2008 Last Editorial Review: 2/7/2008